413 related articles for article (PubMed ID: 24620349)
1. Biology of tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Blood; 2014 May; 123(19):2934-43. PubMed ID: 24620349
[TBL] [Abstract][Full Text] [Related]
2. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
Wood JP; Ellery PE; Maroney SA; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.
Wood JP; Bunce MW; Maroney SA; Tracy PB; Camire RM; Mast AE
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17838-43. PubMed ID: 24127605
[TBL] [Abstract][Full Text] [Related]
4. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
[TBL] [Abstract][Full Text] [Related]
5. Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.
Ellery PE; Maroney SA; Martinez ND; Wickens MP; Mast AE
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):187-95. PubMed ID: 24233486
[TBL] [Abstract][Full Text] [Related]
6. New insights into the biology of tissue factor pathway inhibitor.
Maroney SA; Mast AE
J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
[TBL] [Abstract][Full Text] [Related]
7. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.
Maroney SA; Hansen KG; Mast AE
Curr Opin Hematol; 2013 Sep; 20(5):403-9. PubMed ID: 23839295
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.
Maroney SA; Ellery PE; Wood JP; Ferrel JP; Martinez ND; Mast AE
J Thromb Haemost; 2013 May; 11(5):911-8. PubMed ID: 23480518
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cell-surface TFPIalpha and beta.
Piro O; Broze GJ
J Thromb Haemost; 2005 Dec; 3(12):2677-83. PubMed ID: 16246254
[TBL] [Abstract][Full Text] [Related]
10. TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.
Girard TJ; Tuley E; Broze GJ
Blood; 2012 Feb; 119(5):1256-62. PubMed ID: 22144186
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor: structure-function.
Broze GJ; Girard TJ
Front Biosci (Landmark Ed); 2012 Jan; 17(1):262-80. PubMed ID: 22201743
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
14. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
Mast AE; Ruf W
J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
Dahlbäck B
J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
[TBL] [Abstract][Full Text] [Related]
16. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):9-14. PubMed ID: 26603155
[TBL] [Abstract][Full Text] [Related]
17. The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg
van Doorn P; Rosing J; Wielders SJ; Hackeng TM; Castoldi E
J Thromb Haemost; 2017 Jan; 15(1):140-149. PubMed ID: 27801970
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
[TBL] [Abstract][Full Text] [Related]
20. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.
Wood JP; Petersen HH; Yu B; Wu X; Hilden I; Mast AE
Blood Adv; 2017 Dec; 1(27):2692-2702. PubMed ID: 29291252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
